Healthtech Solutions, Inc. (HLTT), Parent Company of Cutting-Edge Medical Technology Companies, Files Reg A With SEC
March 17, 2021 08:30 ET
|
Healthtech Solutions, Inc.
March 8, 2021, filing to raise up to $75 million. Maximum of 1,500,000 shares of Series B preferred stock offered at price of $50 per share.Healthtech Solutions, Inc. is organized to pursue...
Healthtech Solutions, Inc. (HLTT), Parent Company of Medi-Scan Inc., Announces Incorporation of a New Subsidiary Called RevHeart, Inc.
March 16, 2021 08:30 ET
|
Healthtech Solutions, Inc.
New subsidiary will further the Company’s research into treating COVID-related heart muscle injury. A patent has been filed for a therapy to ameliorate and potentially repair myocardial damage. NEW...
InCarda Therapeutics Announces Enrollment of First U.S. Patient in Phase 2 INSTANT Trial of InRhythm™ for Treatment of Atrial Fibrillation
January 19, 2021 08:05 ET
|
InCarda Therapeutics, Inc.
SAN FRANCISCO, Jan. 19, 2021 (GLOBE NEWSWIRE) -- InCarda Therapeutics, Inc. (“InCarda”), a privately-held biopharmaceutical company developing first-of-their-kind inhaled therapies for...
Integer’s Alden, N.Y. Location Breaks Ground on Building Expansion
January 14, 2021 16:05 ET
|
Integer Holdings Corporation
~ Expansion to Significantly Increase Plant’s Production Capacity of Xcellion® Lithium Ion Rechargeable Batteries ~ PLANO, Texas, Jan. 14, 2021 (GLOBE NEWSWIRE) -- Integer Holdings Corporation...
InCarda Therapeutics Presents Positive New Data from Phase 2 Study of InRhythm™ in Patients with Paroxysmal Atrial Fibrillation at American Heart Association Scientific Sessions 2020
November 13, 2020 10:00 ET
|
InCarda Therapeutics, Inc.
Data Demonstrate Achievement of Rapid Conversions from Atrial Fibrillation to Normal Sinus Rhythm Study Findings Provide Proof of Concept for First-of-its-Kind Inhaled Antiarrhythmic for Treatment of...
InCarda Therapeutics Raises $30 Million Through First Close of Series C Equity Financing
October 21, 2020 08:05 ET
|
InCarda Therapeutics, Inc.
Proceeds to Support Ongoing Clinical Development of InRhythm™, A First-of-its-Kind Inhaled Antiarrhythmic for Treatment of Paroxysmal Atrial Fibrillation (PAF) Positive Phase 2 Data Scheduled for...
CB Scientific, Inc. (CBSC) Announces the Launch of My-Cardia ECG Products and Services in Thailand
October 08, 2020 08:00 ET
|
CB Scientific, Inc.
ESCONDIDO, Calif., Oct. 08, 2020 (GLOBE NEWSWIRE) -- via Network Wire -- CB Scientific. Inc. (OTC:CBSC) ("CBSC" or the "Company"), a provider of innovative products and services for the ambulatory...
CB Scientific, Inc. (CBSC) Announces Completion of Asset Purchase Agreement and Commencement of Its ECG Monitoring Business
September 22, 2020 08:00 ET
|
CB Scientific, Inc.
ESCONDIDO, Calif., Sept. 22, 2020 (GLOBE NEWSWIRE) -- via NetworkWire -- CB Scientific, Inc. (OTC: CBSC) (“CBSC” or the “Company”), a provider of innovative products and services for the ambulatory...
Electrosurgical Generators Market revenue to hit USD 2.5 Bn by 2025: Global Market Insights, Inc.
December 22, 2019 19:00 ET
|
Global Market Insights, Inc
Selbyville, Delaware, Dec. 22, 2019 (GLOBE NEWSWIRE) -- According to latest report “Electrosurgical Generators Market by Type (Bipolar, Monopolar), Application (Optical, Gynecology, Dermatology,...
CITIZEN CPR FOUNDATION ISSUES A CALL TO ACTION TO SAVE LIVES FROM SUDDEN CARDIAC ARREST
December 13, 2019 12:07 ET
|
Citizen CPR Foundation
Seattle, Washington, Dec. 13, 2019 (GLOBE NEWSWIRE) -- Wrapping up four days of cutting-edge education and motivation to help reinforce the strength of the “chain of survival,” the Citizen CPR...